In a clinical trial evaluating immunotherapy in triple-negative breast cancer (TNBC), the expression level of PD-L1 on tumor-associated macrophage (TAMs) was positively correlated with the response to immunotherapy, indicating the vital role of TAMs in the TME [34]. This evidence concerns the gene CD274 and neoplasm.